查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1182035

猴痘疫苗和治療全球市場研究與預測：副產品（疫苗、藥物、疫苗免疫球蛋白）、性別、給藥途徑、最終用戶、區域分析，2022-2029 年

Global Monkeypox Vaccine and Treatment Market Size study & Forecast, by Product (Vaccine, Drugs, Vaccinia Immune Globulin ) by Gender, by Route of Administration, by End Use and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球猴痘疫苗和治療藥物市場價值約為 7834 萬美元，預計在 2022-2029 年預測期內將增長 10.2% 以上。

猴痘病毒是痘病毒科正痘病毒屬的成員，是猴痘的病原體。消滅天花運動中採用的猴痘疫苗也有預防作用。猴痘疫苗和治療市場正在擴大，原因包括猴痘感染率不斷上升以及政府為防止猴痘爆發而付出的巨大努力。然而，與疫苗和治療相關的副作用可能會阻礙市場增長。

例如，根據美國疾病控制與預防中心的信息，截至2022年8月9日，全球共有31800例猴痘確診病例，其中31425例發生在從未報告過猴痘的國家。據估計，同時，過去有375個國家被證實感染了猴痘。此外，根據《New England Journal of Medicine》的報導，在 2022 年 4 月至 2022 年 6 月期間，男男性行為者和 LGBT 群體佔全球 16 個國家猴痘病例的 98%。因此，全球範圍內猴痘病流行率的上升促進了市場的增長。此外，疫苗開發技術的不斷進步以及政府對研究和活動的積極主動性正在創造市場的利潤豐厚的增長。然而，在整個 2022-2029 年的預測期內，猴痘疫苗和治療的副作用將抑制市場增長。

全球猴痘疫苗和治療市場研究考慮的主要區域包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。在這些地區中，北美將在 2021 年佔據最高份額，原因是疾病流行率上升和政府加大研發投入等因素將為市場提供有利可圖的增長。據預測，由於沙門氏菌感染數量增加和疫苗研發增加等因素，亞太地區預計將呈現最快的市場增長速度。

本研究的目的是揭示近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。該報告旨在包括被調查國家工業的定性和定量方面。

它還提供了有關關鍵方面的詳細信息，例如將定義市場未來增長的驅動因素和挑戰。此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。

目錄

第一章執行摘要

  • 市場快照
  • 2019-2029 年全球市場和細分市場的估計和預測
    • 2019-2029 年按地區分列的猴痘疫苗和治療藥物市場
    • 2019-2029 年按產品分列的猴痘疫苗和治療藥物市場
    • 猴痘疫苗和治療市場：性別歧視，2019-2029
    • 2019-2029 年按給藥途徑劃分的猴痘疫苗和治療市場
    • 猴痘疫苗和治療市場最終用途，2019-2029
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第二章猴痘疫苗和治療藥物全球市場的定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 產業進化
  • 調查目標年份
  • 貨幣兌換率

3 全球猴痘疫苗和治療市場動態

  • 猴痘疫苗和治療藥物市場影響分析 (2019-2029)
    • 市場驅動力
      • 猴痘的發病率和流行率增加
      • 政府努力抗擊猴痘疫情
    • 市場挑戰
      • 與疫苗和治療相關的副作用
    • 市場機會
      • 疫苗開發活動的進展

第四章猴痘疫苗和治療的全球市場，行業分析

  • 波特五力模型
    • 供應商的議價能力
    • 買方議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭對手之間的競爭
  • 波特五力模型的未來方法（2019-2029）
  • PEST分析
    • 政治的
    • 經濟的
    • 社會的
    • 技術的
  • 招商引資模式
  • 分析師結論/建議
  • 頂級投資機會
  • 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的整體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

6 全球猴痘疫苗和療法市場，按產品分類

  • 市場快照
  • 猴痘疫苗和療法的全球市場：按產品分類，性能潛力分析
  • 2019-2029 年全球猴痘疫苗和療法市場、按產品估計和預測
  • 猴痘疫苗和治療市場，細分分析
    • 疫苗接種
    • 藥品
    • 牛痘免疫球蛋白 (VIG)

第 7 章：猴痘疫苗和治療藥物的全球市場：性別歧視

  • 市場快照
  • 猴痘疫苗和療法的全球市場：性別、性能和潛力分析
  • 全球猴痘疫苗和療法市場，按性別估計和預測 (2019-2029)
  • 猴痘疫苗和治療市場，細分分析
    • 男性
    • 女士
    • 其他

8 全球猴痘疫苗和療法市場，按給藥途徑

  • 市場快照
  • 全球猴痘疫苗和治療市場：按給藥途徑、性能-潛力分析
  • 2019-2029 年全球猴痘疫苗和療法市場、按給藥途徑估計和預測
  • 猴痘疫苗和治療市場，細分分析
    • 口服劑
    • 注射

9 全球猴痘疫苗和治療市場，按最終用戶分類

  • 市場快照
  • 猴痘疫苗和療法的全球市場：最終用途的性能和潛力分析
  • 全球猴痘疫苗和療法市場，按最終用途估計和預測 2019-2029
  • 猴痘疫苗和治療市場，細分分析
    • 醫院
    • 專科診所
    • 其他

10 全球猴痘疫苗和治療市場：區域分析

  • 猴痘疫苗和治療市場：按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年各產品的估計和預測
      • 2019-2029 年按性別分類的估計和預測
      • 最終用戶的估計和預測，2019-2029
    • 加拿大
  • 歐洲猴痘疫苗和治療市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 歐洲其他地區
  • 亞太地區猴痘疫苗和治療藥物市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉丁美洲猴痘疫苗和治療藥物市場概況
    • 巴西
    • 墨西哥
  • 世界其他地區

第 11 章 競爭信息

  • 頂級市場戰略
  • 公司簡介
    • Bavarian Nordic
      • 主要信息
      • 概述
      • 財務信息（視數據可用性而定）
      • 產品概要
      • 最近的發展
    • SIGA Technologies
    • Chimerix
    • Emergent
    • Gilead Sciences, Inc.
    • Sanofi SA
    • Emcure Pharma
    • Jinan Jinda Pharmaceutical Chemistry Co., Ltd
    • Reliance Life Sciences
    • Haffkine Institute

第十二章調查過程

  • 調查過程
    • 數據挖掘
    • 分析
    • 市場估計
    • 驗證
    • 出版物
  • 調查屬性
  • 調查先決條件

Global Monkeypox Vaccine and Treatment Market is valued at approximately USD 78.34 million in 2021 and is anticipated to grow with a healthy growth rate of more than 10.2% over the forecast period 2022-2029. The monkeypox virus, a species of the Orthopoxviral genus in the family Poxviridae, is the culprit behind monkeypox. The monkeypox vaccines employed in the smallpox eradication operation also offered protection from that disease. The Monkeypox Vaccine and Treatment market is expanding because of factors such an as Increase in the prevalence of monkeypox infection, and high government initiatives to combat outbreaks of monkeypox. However, Side effects associated with the vaccine and treatment may halt market growth.

For instance, according to information from the Centers for Disease Control and Prevention, there are estimated to be 31,800 confirmed cases of monkeypox worldwide through August 9, 2022, of which 31,425 are in nations that have never previously reported monkeypox. While there are 375 nations where monkeypox has previously been documented. Additionally, it was discovered that between April and June 2022, 98% of the monkeypox infections in 16 nations worldwide were in males who have sex with men and LGBT groups, per a report published in the New England Journal of Medicine. Thus, the rising prevalence of monkey pox disease across the globe is catering for the growth of the market. Furthermore, rising technological advancement in the development of vaccines and rising government initiatives for research and activities are creating lucrative growth in the market. However, the side effects of the Monkeypox Vaccine and Treatment stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Monkeypox Vaccine and Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Among these regions, North America holds the highest share in the year 2021 owing to factors such as the rising prevalence of disease, and rising government investment in research and development is anticipated to provide lucrative growth in the market. Asia Pacific is projected to witness the fastest region owing to factors such as rising number of monkeypox infections and increasing research and development for developing vaccines driving the growth of market.

Major market players included in this report are:

Bavarian Nordic

SIGA Technologies

Chimerix Inc

Emergent

Gilead Sciences, Inc.

Sanofi SA

Emcure Pharma Company

Jinan Jinda Pharmaceutical Chemistry Co., Ltd

Reliance Life Sciences

Haffkine Institute for training research and testing

Recent Developments in the Market:

  • In February 2022, Bavarian Nordic A/S announced the contract of 2.5 million doses of an additional order of JYNNEOS from the U.S.
  • In Aug 2022, the tecovirimat (oral) by SIGA was licenced by the U.K. for the management of monkeypox and other indications in adults and children with body weights greater than 13 kg. The medication has also been given the go-ahead to treat monkeypox sickness in other European nations.

Global Monkeypox Vaccine and Treatment Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, Gender, Route of Administration, End Use, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Vaccine

Drugs

Vaccinia Immune Globulin (VIG)

By Gender:

Male

Female

Others

Route of Administration:

Oral

Injectables

By End Use:

Hospitals

Specialty ClinicsOthers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Monkeypox Vaccine and Treatment Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Monkeypox Vaccine and Treatment Market, by Product, 2019-2029 (USD Million)
    • 1.2.3. Monkeypox Vaccine and Treatment Market, by Gender, 2019-2029 (USD Million)
    • 1.2.4. Monkeypox Vaccine and Treatment Market, by Route of Administration, 2019-2029 (USD Million)
    • 1.2.5. Monkeypox Vaccine and Treatment Market, by End Use, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Monkeypox Vaccine and Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Monkeypox Vaccine and Treatment Market Dynamics

  • 3.1. Monkeypox Vaccine and Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence and prevalence of Monkeypox
      • 3.1.1.2. Government initiatives to combat an outbreak of monkeypox
    • 3.1.2. Market Challenges
      • 3.1.2.1. Side effects associated with the vaccine and treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in vaccine development activities

Chapter 4. Global Monkeypox Vaccine and Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Monkeypox Vaccine and Treatment Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Monkeypox Vaccine and Treatment Market by Product, Performance - Potential Analysis
  • 6.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by Product 2019-2029 (USD Million)
  • 6.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
    • 6.4.1. Vaccine
    • 6.4.2. Drugs
    • 6.4.3. Vaccinia Immune Globulin (VIG)

Chapter 7. Global Monkeypox Vaccine and Treatment Market, by Gender

  • 7.1. Market Snapshot
  • 7.2. Global Monkeypox Vaccine and Treatment Market by Gender, Performance - Potential Analysis
  • 7.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by Gender 2019-2029 (USD Million)
  • 7.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
    • 7.4.1. Male
    • 7.4.2. Female
    • 7.4.3. Others

Chapter 8. Global Monkeypox Vaccine and Treatment Market, by Route of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Monkeypox Vaccine and Treatment Market by Route of Administration, Performance - Potential Analysis
  • 8.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Million)
  • 8.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
    • 8.4.1. Oral
    • 8.4.2. Injectables

Chapter 9. Global Monkeypox Vaccine and Treatment Market, by End Use

  • 9.1. Market Snapshot
  • 9.2. Global Monkeypox Vaccine and Treatment Market by End Use, Performance - Potential Analysis
  • 9.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by End Use 2019-2029 (USD Million)
  • 9.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
    • 9.4.1. Hospitals
    • 9.4.2. Specialty Clinics
    • 9.4.3. Others

Chapter 10. Global Monkeypox Vaccine and Treatment Market, Regional Analysis

  • 10.1. Monkeypox Vaccine and Treatment Market, Regional Market Snapshot
  • 10.2. North America Monkeypox Vaccine and Treatment Market
    • 10.2.1. U.S. Monkeypox Vaccine and Treatment Market
      • 10.2.1.1. Product breakdown estimates & forecasts, 2019-2029
      • 10.2.1.2. Gender breakdown estimates & forecasts, 2019-2029
      • 10.2.1.3. ijkl breakdown estimates & forecasts, 2019-2029
      • 10.2.1.4. End Use breakdown estimates & forecasts, 2019-2029
    • 10.2.2. Canada Monkeypox Vaccine and Treatment Market
  • 10.3. Europe Monkeypox Vaccine and Treatment Market Snapshot
    • 10.3.1. U.K. Monkeypox Vaccine and Treatment Market
    • 10.3.2. Germany Monkeypox Vaccine and Treatment Market
    • 10.3.3. France Monkeypox Vaccine and Treatment Market
    • 10.3.4. Spain Monkeypox Vaccine and Treatment Market
    • 10.3.5. Italy Monkeypox Vaccine and Treatment Market
    • 10.3.6. Rest of Europe Monkeypox Vaccine and Treatment Market
  • 10.4. Asia-Pacific Monkeypox Vaccine and Treatment Market Snapshot
    • 10.4.1. China Monkeypox Vaccine and Treatment Market
    • 10.4.2. India Monkeypox Vaccine and Treatment Market
    • 10.4.3. Japan Monkeypox Vaccine and Treatment Market
    • 10.4.4. Australia Monkeypox Vaccine and Treatment Market
    • 10.4.5. South Korea Monkeypox Vaccine and Treatment Market
    • 10.4.6. Rest of Asia Pacific Monkeypox Vaccine and Treatment Market
  • 10.5. Latin America Monkeypox Vaccine and Treatment Market Snapshot
    • 10.5.1. Brazil Monkeypox Vaccine and Treatment Market
    • 10.5.2. Mexico Monkeypox Vaccine and Treatment Market
  • 10.6. Rest of The World Monkeypox Vaccine and Treatment Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. Bavarian Nordic
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject to Data Availability)
      • 11.2.1.4. Product Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. SIGA Technologies
    • 11.2.3. Chimerix
    • 11.2.4. Emergent
    • 11.2.5. Gilead Sciences, Inc.
    • 11.2.6. Sanofi SA
    • 11.2.7. Emcure Pharma
    • 11.2.8. Jinan Jinda Pharmaceutical Chemistry Co., Ltd
    • 11.2.9. Reliance Life Sciences
    • 11.2.10. Haffkine Institute

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Monkeypox Vaccine and Treatment Market, report scope
  • TABLE 2. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by Product 2019-2029 (USD Million)
  • TABLE 4. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by Gender 2019-2029 (USD Million)
  • TABLE 5. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by Route of Administration 2019-2029 (USD Million)
  • TABLE 6. Global Monkeypox Vaccine and Treatment Market estimates & forecasts by End Use 2019-2029 (USD Million)
  • TABLE 7. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global Monkeypox Vaccine and Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. Global Monkeypox Vaccine and Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 18. U.S. Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. U.S. Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 20. Canada Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 21. Canada Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. Canada Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 23. UK Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 24. UK Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. UK Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 26. Germany Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 27. Germany Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. Germany Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 29. France Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 30. France Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. France Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 32. Italy Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 33. Italy Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Italy Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 35. Spain Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 36. Spain Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. Spain Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 38. RoE Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 39. RoE Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. RoE Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 41. China Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 42. China Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. China Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 44. India Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 45. India Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. India Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 47. Japan Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 48. Japan Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. Japan Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 50. South Korea Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 51. South Korea Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. South Korea Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 53. Australia Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 54. Australia Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. Australia Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 57. RoAPAC Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. RoAPAC Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 59. Brazil Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 60. Brazil Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Brazil Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 62. Mexico Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 63. Mexico Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. Mexico Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 65. RoLA Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 66. RoLA Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. RoLA Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 68. Row Monkeypox Vaccine and Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 69. Row Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. Row Monkeypox Vaccine and Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 71. List of secondary sources, used in the study of global Monkeypox Vaccine and Treatment Market
  • TABLE 72. List of primary sources, used in the study of global Monkeypox Vaccine and Treatment Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Monkeypox Vaccine and Treatment Market, research methodology
  • FIG 2. Global Monkeypox Vaccine and Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Monkeypox Vaccine and Treatment Market, key trends 2021
  • FIG 5. Global Monkeypox Vaccine and Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Monkeypox Vaccine and Treatment Market, porters 5 force model
  • FIG 7. Global Monkeypox Vaccine and Treatment Market, pest analysis
  • FIG 8. Global Monkeypox Vaccine and Treatment Market, value chain analysis
  • FIG 9. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Monkeypox Vaccine and Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Monkeypox Vaccine and Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Monkeypox Vaccine and Treatment Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Monkeypox Vaccine and Treatment Market 2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Monkeypox Vaccine and Treatment Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Monkeypox Vaccine and Treatment Market 2019 & 2029 (USD Million)
  • FIG 19. Global Monkeypox Vaccine and Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable